Alzheimer's disease pathophysiology in the Retina

Area of Science:

• Neuroscience
• Ophthalmology
• Biomarkers

Background:

• Alzheimer's disease (AD) pathology, including amyloid-beta (Aβ) deposits and tau, is found in the retinas of patients.
• Retinal vascular abnormalities, inflammation, and neurodegeneration are observed in mild cognitive impairment and AD dementia.
• Retinal and brain pathologies in AD show corresponding severity and patterns.

Purpose of the Study:

• To explore the retina as a potential site for noninvasive diagnosis and tracking of Alzheimer's disease.
• To investigate the correlation between retinal and brain pathologies in Alzheimer's disease.
• To assess the utility of ophthalmic imaging for detecting AD hallmarks in the retina.

Main Methods:

• Histological, biochemical, and clinical studies were used to analyze retinal and brain tissues.
• Proteomics analysis compared protein expression patterns in the retina and brain of AD patients.
• Investigational ophthalmic imaging technologies were employed to detect AD-specific changes in the retina.

Main Results:

• Proteomics revealed similar dysregulated pathways in the retina and brain, including inflammation, neurodegeneration, and mitochondrial dysfunction.
• Ophthalmic imaging can detect AD-specific amyloid deposits, vasculopathy, and neurodegeneration in living patients.
• Retinal alterations correlate with disease stage and brain pathology.

Conclusions:

• The retina serves as a viable CNS target for Alzheimer's disease diagnosis and monitoring.
• Ophthalmic imaging modalities show promise for clinical assessment of AD.
• Further research with larger cohorts and standardized techniques is needed to validate retinal biomarkers for AD.